节点文献

骨髓增生异常综合征红细胞酶谱测定临床应用研究

Clinical Use of Determination of Erythrocyte Enzyme Activity in Myelodysplastic Syndromes

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 梁晓华林果为刘文廉

【Author】 Liang xiaohua; lin guowei; Liu Wenlian(Hematology Department, Huashan Hospital, shanghai Medical University, Shanghai)

【机构】 上海医科大学华山医院血液病研究室

【摘要】 本文比较了23例MDS和9例AA患者4种红细胞酶的活性,除醛缩酶(ALD)外,丙酮酸激酶(PK)、嘌呤核苷磷酸化酶(PNP)、腺苷脱氨酶(ADA)在AA患者均接近正常,和MDS差异显著,尤其是PK和PNP差异显著。据此联合检测红细胞4种酶活性,建立了MDS和AA的判别函数式:PMDS=-5.04107+0.25674PK+1.67651ALD+0.03481PNP+0.25024ADA,PAA=-7.90038+0.3846PK+1.49621ALD+0.0805PNP+0.13237ADA。内部回代结果,判别敏感度MDS为82.61%,AA为77.78%,特异度MDS可达90.48%,AA仅为63.64%。结果表明,该判别函数式可反映红系病态造血用于临床作为MDS诊断的辅助指标。

【Abstract】 The activities of four erythrocyte enzymes, pyruvate kinase(PK), aldolase(ALD), purine nucleoside phosphorylase(PNP), and adenosine deaminase(ADA) were determined among 23 patients with myelodysplastic syndromes(MDS) and 9 cases of aplastic anemia(AA). The comparison study showed that erythrocyte enzyme activities, except ALD, in patient with AA were close to the normal range and were significantly different from that of MDS patients, expecially for PK and PNP activities. A discriminant function for distinguishing MDS from AA was established as follow: P(MDS)=-5.04107+0.25674PK+1.67651ALD+0. 03481PNP+0.25024ADA. P(AA)=-7.90038+0.3846PK+1.49621ALD+0.0805PNP+0.13237ADA. For the diagnosis of MDS, the sensitivity was 82.61%, the specificity was 90.48%, This discriminant function could reflect the dyshematopoiesis and be used as the supplementary diagnostic index of MDS.

  • 【文献出处】 临床血液学杂志 ,JOURNAL OF CLINICAL HEMOTOLOGY , 编辑部邮箱 ,1995年02期
  • 【分类号】R551.3
  • 【下载频次】8
节点文献中: 

本文链接的文献网络图示:

本文的引文网络